secwatch.observer — SEC 8-K summary
======================================

Issuer:     LianBio (LIANY)
CIK:        0001831283
Form:       8-K
Filed at:   2023-03-17T23:59:59+00:00
Accession:  0001831283-23-000025
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CFO Yi Larson gets new 3-year employment contract with $510K base salary
------------------------------------------------------------------------

- Initial term from Oct 1, 2022 to Sep 30, 2025, with auto-renewal for one-year periods.
- Annual base salary $510,000; target discretionary bonus $255,000 per year.
- Severance includes 12 months base salary plus repatriation expenses if terminated without cause or for good reason.
- Within 12 months after a change in control, acceleration of unvested equity and relocation benefits added.
- New contract replaces Sept 2021 agreement; includes perpetual confidentiality and 12-24 month non-compete/non-solicit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831283/000183128323000025/0001831283-23-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831283/000183128323000025/lian-20230314.htm
  HTML page:      https://secwatch.observer/filing/0001831283-23-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer